The effects of CSC on ACE2 expression in oral cells suggests the possibility of therapeutic intervention, since ACE2 antibodies or soluble recombinant ACE2 can attenuate viral entry and infection by SARS-CoV-2 in other cells [17,47]. The gene discussed is ACE2; the disease is infection.